Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company.
RBGLY has been the subject of a number of analyst reports. Royal Bank Of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, October 23rd. Jefferies Financial Group reissued a “hold” rating on shares of Reckitt Benckiser Group in a report on Wednesday. Barclays raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Monday, December 1st. Morgan Stanley cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Monday, October 27th.
Get Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Up 1.8%
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- Hit Your Retirement “Freedom Number” (Without $1 Million)
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
